. Validation of a specific gene signature in AML cells with IDH1-R132H mutation. (A and B) GSEA of differentially up-(206 genes; A) and down-regulated (122 genes; B) genes between WT IDH1 HL60 clones and mutant IDH1-R132H HL60 clones is generated from primary AML patients specimens with mutant IDH1-R132H cells (30 patients) compared with those with WT IDH1 cells (387 patients) from the cohort available under GEO accession no. GSE6891 (Verhaak et al., 2009 ). (C) Analysis of CEBPα gene expression during the normal myelopoiesis in human from HemaExplorer/Miles database. (D) Venn diagrams depicting the number of common genes between the mutant IDH1-R132 signature obtained in our study and APL+ATRA signatures from different published cohorts of NB4 cells (Csomós et al., 2010; Martens et al., 2010) and APL patients (Stegmaier et al., 2004) before and after ATRA treatment. Gene names colored in red correspond to up-regulated genes in both signatures, in blue to down-regulated genes in both signatures, in bold to genes down-regulated in our study and up-regulated in the signatures from literature and in italic, to genes up-regulated in our study and down-regulated in the signatures from the literature. Table S1 , available as a PDF, shows the list of up-and down-regulated genes in mutant IDH1-R132H AML cells compared with WT IDH1 cells. 
